Stay updated on Epacadostat Combo with Pembrolizumab in Sarcoma Clinical Trial
Sign up to get notified when there's something new on the Epacadostat Combo with Pembrolizumab in Sarcoma Clinical Trial page.

Latest updates to the Epacadostat Combo with Pembrolizumab in Sarcoma Clinical Trial page
- Check5 days agoChange DetectedRevision: v3.4.3 replaces the prior v3.4.2. This appears to be an internal version update with no visible changes to the page’s study details or user-facing content.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check34 days agoChange DetectedThe page now displays Revision: v3.4.2 and removes the older funding/operating status notice, which are maintenance updates with no impact on study information or how users interact with the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check41 days agoChange DetectedA site-wide notice about government funding lapse and NIH Clinical Center operating status has been added, and the page version has been updated to Revision: v3.4.1 (replacing v3.4.0). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check48 days agoChange DetectedAdded: Show glossary, Last Update Submitted that Met QC Criteria, No FEAR Act Data, and Revision: v3.4.0; Removed: Last Update Submitted that met QC Criteria, No FEAR Act data, and Revision: v3.3.4. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check62 days agoChange DetectedRevision label updated from v3.3.3 to v3.3.4 on the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check84 days agoChange DetectedAdded a Locations section with New York as a study site. Removed the separate New York Locations listing and the HHS Vulnerability Disclosure footer; updated the page to revision v3.3.3.SummaryDifference0.2%

Stay in the know with updates to Epacadostat Combo with Pembrolizumab in Sarcoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Epacadostat Combo with Pembrolizumab in Sarcoma Clinical Trial page.